Intermediate-Timed Alemtuzumab May be Associated with Increased Graft Rejection in Reduced-Intensity Bone Marrow Transplant for Sickle Cell Disease

Saved in:
Bibliographic Details
Published inBiology of blood and marrow transplantation Vol. 24; no. 3; p. S332
Main Authors Patel, Krupesh, Agarwal, Shreya, Durning, Nancy, Hankewycz, Melanie, Gillio, Alfred P., Adler-Brecher, Barbara, Haugh, Jeanette, Krajewski, Jennifer
Format Journal Article
LanguageEnglish
Published 01.03.2018
Online AccessGet full text

Cover

More Information
ISSN:1083-8791
DOI:10.1016/j.bbmt.2017.12.391